Bruker Corporation's stock soared 10.55% during intraday trading on Wednesday, following the release of its first-quarter 2026 financial results that significantly exceeded analyst expectations.

The scientific instruments maker reported adjusted earnings per share of $0.31 for the quarter, beating the IBES consensus estimate of $0.23. Revenue reached $823.4 million, also surpassing the estimated $796.4 million. The company maintained its full-year outlook, projecting revenue between $3.57 billion and $3.60 billion and adjusted EPS in the range of $2.10 to $2.15, aligning with market expectations.

Despite noting continued weakness in U.S. academic demand and headwinds from tariffs and currency impacts, Bruker highlighted solid academic orders outside the U.S. and strong AI-driven demand in semiconductor metrology and laboratory software. The better-than-expected quarterly performance and reaffirmed guidance have fueled investor optimism, leading to the significant stock price increase.